Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
2017/0266157 METHODS FOR WOUND HEALING AND SCAR PREVENTION
The present invention is related to a compound of formula (I) ##STR00001## or a pharmaceutically acceptable salt or ester thereof. The present invention is...
2017/0266156 METHOD FOR PREVENTING CANCER BY USING PHTHALIDES
The present invention relates to a method for preventing cancer by using a phthalide compound, wherein the phthalide compound has an effect of increasing the...
2017/0266155 METHOD FOR ENHANCING THE OXYGENATION LEVEL OF TISSUE CELLS AS AN ALTERNATIVE METHOD FOR HYPERBARIC OXYGEN THERAPY
The present invention relates to a method for substituting for or acting with the hyperbaric oxygen therapy to improve hypoxia, comprising the step of:...
2017/0266154 METHOD FOR TREATING ALZHEIMER'S DISEASE AND 2, 3-BIPHOSPHOGLYCERATE METABOLISM DISORDER INDUCED
The present invention relates to a method for treating Alzheimer's disease and 2,3-BPG metabolic disorder induced morbidities, comprising administrating a...
2017/0266153 COMPOSITIONS PURPOSEFULLY SELECTED COMPRISING PURIFIED CANNABINOIDS AND/OR PURIFIED TERPENES
Disclosed herein are new compositions comprising a purified cannabinoid and a purified terpene. In one embodiment, the compositions comprise one or more...
2017/0266152 PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF
The present invention relates to methods for preventing or treating acute or chronic heart failure and for reducing the risk of cardiovascular death,...
2017/0266151 Novel salts of 3-[(DIMETHYLAMINO)METHYL]-N--1-BENZOFURAN-2-CARBOXAMIDE, related crystalline forms, method for...
Described herein are salts of 3-[(dimethylamino)methyl]-N-{2-[4-(hydroxycarbamoyl)phenoxy]ethyl}-1-benz- ofuran-2-carboxamide, in particular that of formula...
2017/0266150 USE OF SUBSTITUTED HEXITOLS INCLUDING DIANHYDROGALACTITOL AND ANALOGS TO TREAT NEOPLASTIC DISEASE AND CANCER...
The use of dianhydrogalactitol provides a novel therapeutic modality for the treatment of glioblastoma multiforme and medulloblastoma. Dianhydrogalactitol acts...
2017/0266149 SOLID FORMS OF SELECTIVE ANDROGEN RECEPTOR MODULATORS
The present invention relates to solid forms of (S)--N-(4-cyano-3-(trifluoromethyl)phenyl)-3-(4-cyanophenoxy)-2-hydroxy-2- -methylpropanamide and process for...
2017/0266148 COMPOSITIONS AND METHODS FOR PRODUCING ELEVATED AND SUSTAINED KETOSIS
Beta-hydroxybutyrate mineral salts in combination with medium chain fatty acids or an ester thereof such as medium chain triglycerides were used to induce...
2017/0266147 METHODS OF INCREASING LATENCY OF ANESTHETIC INDUCTION USING KETONE SUPPLEMENTATION
Provided are methods for delaying the onset of anesthesia in a subject.
2017/0266146 COMPOSITIONS AND METHODS FOR TREATMENT OF RETINAL DEGENERATIVE DISEASES
This disclosure relates to compositions for use in treatment of Alzheimer's Disease, and/or a ocular and retinal degenerative disease, such as age related...
2017/0266145 METHODS OF INDUCING METABOLIC MATURATION OF HUMAN PLURIPOTENT STEM CELLS-DERIVED HEPATOCYTES
Provided are methods of increasing metabolic maturation of an immature hepatocyte, by contacting an immature hepatocyte which expresses alpha-fetoprotein (AFP)...
2017/0266144 Compositions and Methods for Diagnosis and Treatment of Metabolic Syndrome
Compositions including an odd chain fatty acid, and salts and derivatives thereof, and methods for metabolic syndrome treatment and prophylaxis are provided,...
2017/0266143 METHODS OF THERAPEUTIC MONITORING OF PHENYLACETIC ACID PRODRUGS
The present disclosure provides methods for adjusting the dosage of PAA prodrugs (e.g., HPN-100, PBA) based on measurement of PAA and PAGN in plasma and...
2017/0266142 Method Of Treating Chronic Obstructive Pulmonary Disease (CPD) With Verproside
A composition comprising a purified extract isolated from Pseudolysimachion rotundum var. subintegrum containing abundant amount of active ingredient or the...
2017/0266141 METHODS AND MATERIALS FOR REDUCING ISCHEMIA-REPERFUSION INJURY
This document provides methods and materials for reducing ischemia-reperfusion injury. For example, methods and materials for administering ABA to reduce...
2017/0266140 Compositions for Modulating Cancer Stem Cells and Uses Therefor
Disclosed are compositions and methods for modulating cancer stem cells. More particularly, the present invention discloses the use of lysine demethylase (LSD)...
2017/0266139 INJECTABLE RESINIFERATOXIN
The present invention provides compositions and methods for relieving pain at a site in a human or animal in need thereof by administering at a discrete site...
2017/0266138 METHODS OF TREATMENT OF ACNE VULGARIS USING TOPICAL DAPSONE COMPOSITIONS
Dapsone compositions can be useful for treating acne. The methods and formulations disclosed herein show efficacy for treating acne vulgaris and/or post...
2017/0266137 LIPOLYTIC METHODS
Compositions, formulations, methods, and systems for treating regional fat deposits comprise contacting a targeted fat deposit with a composition comprising...
2017/0266136 COMPOUNDS FOR THE TREATMENT OF MITOCHONDRIAL DISEASES
Disclosed is a compound of formula (Ia) for the use thereof in the treatment or prevention of diseases relating to the instability of mitochondrial DNA.
2017/0266135 PROCESS FOR PREPARING THE INHALATION FORMULATIONS
The present invention relates to a novel process used for the preparation of dry powder formulations for inhalation.
2017/0266134 DOSAGE OF DASOTRALINE AND METHOD FOR TREATMENT OF ADHD
Dosage forms and treatment regimens employing dasotraline for treating Attention Deficit Hyperactivity Disorder (ADHD) are disclosed. The compositions...
2017/0266133 METHODS AND COMPOSITIONS OF DASOTRALINE FOR TREATMENT OF ADHD
Dosage forms and treatment regimens employing dasotraline for treating Attention Deficit Hyperactivity Disorder (ADHD) are disclosed. The compositions...
2017/0266132 METHOD FOR TREATING HYPERHIDROSIS
The present invention relates to dexmecamylamine and the use of dexmecamylamine, substantially free of exo-R-mecamylamine, in the treatment of hyperhidrosis.
2017/0266131 Modulation of Macrophage Phenotype by Emodin
Methods and materials that can be used to regulate macrophage activation are described. Methods can utilize emodin to bi-directionally modulate macrophage...
2017/0266130 COMPOSITIONS, METHODS FOR MAKING THE COMPOSITIONS, AND METHODS FOR TREATING JOINT DISEASE
The present disclosure relates to a compound, method of making and method of using such compound preferably in the form of a dietary supplement. The...
2017/0266129 FOODS, SYSTEMS, METHODS, AND KITS FOR PROVIDING ELECTROLYTE REPLACEMENT
Described herein are methods, compositions, systems, and kits that effectively deliver a laxative to a patient along with effective electrolyte replenishment...
2017/0266128 TOPICAL REGIONAL NEURO-AFFECTIVE THERAPY IN MAMMALS WITH CANNABINOIDS
A method of treating a disease state or condition in mammals other than humans via topical brainstem afferent stimulation therapy via the administration of a...
2017/0266127 CANNABINOID EMULSION PRODUCT AND PROCESS FOR MAKING THE SAME
A dry consumable preparation and related methods are disclosed. The preparation has a bulking agent, and a cannabinoid and/or a cannabinoid extract containing...
2017/0266126 Use of Cannabinoids in the Treatment of Epilepsy
The present disclosure relates to the use of cannabidiol (CBD) for the treatment of atonic seizures. In particular the CBD appears particularly effective in...
2017/0266125 Multiparticulate L-Menthol Formulations and Related Methods
A pharmaceutical dosage form includes an effective amount of L-menthol for treating a gastrointestinal disorder. The L-menthol is within a plurality of...
2017/0266124 Conjugated Polymer Nanoparticles and Manufacturing Method Thereof
Disclosed are conjugated polymer nanoparticles and a method of producing the same. The conjugated polymer nanoparticles include a conjugated polymer, fatty...
2017/0266123 COATED PARTICLES FOR DRUG DELIVERY
In one aspect, a particle comprising a core containing at least one pharmaceutically active agent and a coating covering the surface of the particle that...
2017/0266122 METHOD OF MAKING PARTICLES FOR USE IN A PHARMACEUTICAL COMPOSITION
The invention relates to a method for making composite active particles for use in a pharmaceutical composition for pulmonary administration, the method...
2017/0266121 SUSTAINED-RELEASE FORMULATIONS OF TOPIRAMATE
Pharmaceutical compositions of topiramate for once-a-day oral administration are provided. The formulations comprise a sustained-release component and an...
2017/0266120 NANOCRYSTALS, COMPOSITIONS, AND METHODS THAT AID PARTICLE TRANSPORT IN MUCUS
Nanocrystals, compositions, and methods that aid particle transport in mucus are provided. In some embodiments, the compositions and methods involve making...
2017/0266119 HYPERBRANCHED POLYGLYCEROL-COATED PARTICLES AND METHODS OF MAKING AND USING THEREOF
Core-shell particles and methods of making and using thereof are described herein. The core is formed of or contains one or more hydrophobic materials or more...
2017/0266118 ALL NATURAL, NON-TOXIC SUBLINGUAL DRUG DELIVERY SYSTEMS
All natural non-toxic sublingual delivery systems improve absorption and onset profiles for numerous actives, along with bioavailability and pharmacokinetics...
2017/0266117 DELAYED RELEASE DRUG FORMULATION
In a delayed release formulation comprising a core containing a drug and a delayed release coating for providing intestinal release, release of the drug in the...
2017/0266116 GASTRO-RETENTIVE SUSTAINED-RELEASE ORAL DOSAGE FORM OF A BILE ACID SEQUESTRANT
Disclosed herein are novel compositions and methods for controlling the release of bile acid sequestrant to the stomach in order to treat or prevent upper GI...
2017/0266115 PALATABLE COMPOSITIONS INCLUDING SODIUM PHENYLBUTYRATE AND USES THEREOF
The present invention features palatable pharmaceutical compositions including sodium phenylbutyrate and methods for the treatment of inborn errors of...
2017/0266114 LIPID VESICLE COMPOSITIONS AND METHODS OF USE
The invention provides delivery systems comprised of stabilized multilamellar vesicles, as well as compositions, methods of synthesis, and methods of use...
2017/0266113 NEBULIZABLE COMPOSITIONS OF QUATERNARY AMMONIUM MUSCARINIC RECEPTOR ANTAGONISTS
Compositions and methods for treatment, prevention, or amelioration of one or more symptoms of bronchoconstrictive disorders are provided. The compositions...
2017/0266112 RESIDENCE STRUCTURES AND RELATED METHODS
Residence structures, systems, and related methods are generally provided. Certain embodiments comprise administering (e.g., orally) a residence structure to a...
2017/0266111 LOCAL ADMINISTRATION-TYPE PHARMACEUTICAL FOR IMPROVING DYSPHAGIA
A dysphagia improving composition characterized in that a substance having an inhibitory action on an angiotensin converting enzyme, which is a degrading...
2017/0266110 DRUG DELIVERY SYSTEM AND METHOD OF TREATING OCULAR DISEASES IN ANIMALS
The present invention relates in general to the field of drug delivery systems for treating ocular diseases in animals, and more specifically, to a drug...
2017/0266109 RAPAMYCIN FORMULATIONS AND METHODS OF THEIR USE
Described herein are liquid rapamycin formulations. Described herein are methods of treating or preventing diseases or conditions, such as choroidal...
2017/0266108 INTRAVENOUS ADMINISTRATION OF TRAMADOL
A method of treating pain, e.g., acute post-operative pain, by administering to a human patient(s) a therapeutically effective dose of tramadol intravenously...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.